pamidronate has been researched along with jaw in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Tanvetyanon, T | 1 |
| Elting, LS; Migliorati, CA; Siegel, MA | 1 |
| Treister, N; Woo, SB | 1 |
| Bonneterre, J; Cortet, B; Facon, T; Maes, JM; Magro, L; Penel, G; Vieillard, MH | 1 |
| Bedogni, A; Bedogni, G; Blandamura, S; Chiarini, L; Ferrari, F; Ferretti, M; Ferronato, G; Lo Muzio, L; Lo Russo, L; Lokmic, Z; Ninfo, V; Nocini, PF; Palumbo, C; Pietrogrande, F; Procopio, O; Ragazzo, M; Saia, G; Tregnaghi, A | 1 |
| Bohle, GC; Carlson, DL; Estilo, CL; Farooki, A; Fornier, M; Halpern, JL; Huryn, JM; Lwin, PT; Riedel, ER; Schoder, H; Tunick, SJ; Van Poznak, CH; Wiliams, T; Zhou, Q | 1 |
| Bruetman, JE; Finn, BC; Young, P | 1 |
| Bennett, CL; Boyd, I; Carson, K; Dimopoulos, M; Edwards, BJ; Farrugia, M; Gounder, M; Marx, R; McKoy, JM; Mehta, J; Migliorati, C; Obadina, E; Raisch, DW; Ruggiero, S; Singhal, S; Trifilio, S; West, D | 1 |
| Abildgaard, N; Gregersen, H; Lund, T; Marker, P; Vangsted, A | 1 |
| Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A | 1 |
| Camacho-Alonso, F; Gómez-García, F; López-Jornet, P; Molina-Miñano, F; Vicente-Ortega, V | 1 |
| Aapro, M; Costa, L; Saad, F | 1 |
| Catalfamo, L; Centofanti, A; Cutroneo, G; De Ponte, FS; Favaloro, A; Runci, M; Siniscalchi, EN | 1 |
| Glotzbecker, B; Mawardi, H; Richardson, P; Woo, SB | 1 |
| Neal, TW; Schlieve, T | 1 |
2 review(s) available for pamidronate and jaw
| Article | Year |
|---|---|
Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Dental Care for Chronically Ill; Diphosphonates; Humans; Imidazoles; Jaw; Mandibular Diseases; Multiple Myeloma; Osteonecrosis; Pamidronate; Practice Guidelines as Topic; Time Factors; Zoledronic Acid | 2006 |
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Antineoplastic Agents; Bone Density Conservation Agents; Diphosphonates; Drug Approval; Female; Humans; Imidazoles; Incidence; Infusions, Intravenous; Jaw; Male; Osteonecrosis; Pamidronate; Precipitating Factors; Tooth Extraction; United States; United States Food and Drug Administration; Zoledronic Acid | 2008 |
13 other study(ies) available for pamidronate and jaw
| Article | Year |
|---|---|
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
Topics: Analgesics; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Jaw; Male; Necrosis; Osteomyelitis; Osteopetrosis; Pain; Pain Measurement; Pamidronate; Prostatic Neoplasms; Quality of Life; Research Design; Surveys and Questionnaires; Time Factors; Treatment Outcome; Zoledronic Acid | 2005 |
Images in clinical medicine. Bisphosphonate-associated osteonecrosis of the jaw.
Topics: Anti-Infective Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorhexidine; Clindamycin; Diphosphonates; Humans; Jaw; Male; Mandible; Mandibular Diseases; Middle Aged; Mouthwashes; Multiple Myeloma; Osteonecrosis; Pamidronate | 2006 |
Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Jaw; Male; Middle Aged; Multiple Myeloma; Orthognathic Surgical Procedures; Osteonecrosis; Osteoporosis; Pamidronate; Prospective Studies; Zoledronic Acid | 2008 |
Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Jaw; Jaw Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Tomography, Spiral Computed; Tooth Extraction; Water; Zoledronic Acid | 2008 |
Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
Topics: Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Infusions, Intravenous; Jaw; Jaw Neoplasms; Male; Mandible; Maxilla; Osteonecrosis; Pamidronate; Retrospective Studies; Risk Factors; Treatment Outcome; Zoledronic Acid | 2008 |
Numb chin syndrome by biphosphonates.
Topics: Aged; Bone Density Conservation Agents; Breast Neoplasms; Chin; Diphosphonates; Female; Humans; Hypesthesia; Jaw; Osteonecrosis; Pamidronate | 2008 |
[Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma].
Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Jaw; Multiple Myeloma; Oral Hygiene; Osteonecrosis; Pamidronate; Risk Factors; Zoledronic Acid | 2009 |
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Jaw; Jaw Diseases; Male; Mandibular Diseases; Maxillary Diseases; Microscopy, Electron, Scanning; Middle Aged; Osteomyelitis; Osteonecrosis; Osteoporosis; Osteoradionecrosis; Pamidronate; Time Factors; Zoledronic Acid | 2010 |
An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats.
Topics: Animals; Bone Density Conservation Agents; Dexamethasone; Diphosphonates; Drug Combinations; Glucocorticoids; Inflammation; Jaw; Jaw Diseases; Male; Neovascularization, Pathologic; Osteonecrosis; Pamidronate; Prospective Studies; Random Allocation; Rats; Rats, Sprague-Dawley; Tooth Extraction | 2010 |
Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases.
Topics: Administration, Oral; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Neoplasms; Breast Neoplasms; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Infusions, Intravenous; Jaw; Male; Osteonecrosis; Pamidronate; Prostatic Neoplasms; RANK Ligand; Zoledronic Acid | 2010 |
Sarcoglycans and integrins in bisphosphonate treatment: immunohistochemical and scanning electron microscopy study.
Topics: Bone Neoplasms; Bone Resorption; Calcification, Physiologic; Cell Adhesion; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Humans; Imidazoles; Immunohistochemistry; Integrins; Jaw; Microscopy, Electron, Scanning; Mouth Mucosa; Osteonecrosis; Pamidronate; Sarcoglycans; Zoledronic Acid | 2013 |
Hematopoietic Cell Transplantation in Patients with Medication-Related Osteonecrosis of the Jaws.
Topics: Aged; Antineoplastic Agents; Diphosphonates; Female; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Jaw; Male; Middle Aged; Osteonecrosis; Pamidronate; Retrospective Studies; Staphylococcus aureus; Transplantation Conditioning; Zoledronic Acid | 2016 |
Medication-Related Osteonecrosis of the Jaws in the Pediatric Population.
Topics: Adolescent; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Child; Child, Preschool; Denosumab; Diphosphonates; Female; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Jaw; Male; Osteonecrosis; Pamidronate; Retrospective Studies; Zoledronic Acid | 2022 |